Delivery Order SPE2DB22D3501-SPE2DB25FXF67
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Bicillin L-A 2,400,000 units in 4mL formulation, with a ceiling value of $16,936.62. This competitively awarded, firm fixed price delivery order is scheduled for ultimate completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Bicillin L-A 1,200,000 units in 2mL vials, with a ceiling value of $1,443.54. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating the contract was competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Bicillin L-A 2,400,000 Units 4mL, an antibiotic medication used to treat bacterial infections. This firm fixed-price delivery order, valued at $2,822.76, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,887.08 for Bicillin L-A 1,200,000 units in 2mL formulation, effective August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,327.87 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of January 31, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,175.24 to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The contract is for the supply of 1,200,000 units of Bicillin L-A 2 mL, a pharmaceutical product, with a period of performance through March 29, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,200,000 units of Bicillin L-A (2 mL) at a firm fixed price of $5,774.16. The order has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical, which provides a comprehensive global...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of the pharmaceutical product Bicillin L-A in 2 milliliter vials. The total potential value of the contract is $76,391.25 and the period of performance extends through February 27, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,488.56 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 1,200,000 units of Bicillin L-A, a medical product, with an ultimate delivery date of April 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to deliver a wide range of pharmaceutical and medical commodities to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract, valued at $3,525.75, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF67Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bicillin L-A 2,400,000 units (4mL) on September 9, 2025, with a ceiling value of $7,568.94. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is scheduled for ultimate completion by September 10, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen's status as a critical prime vendor for DLA reflects its demonstrated capability to meet federal procurement requirements and support defense health initiatives through reliable medical product delivery across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/9/25 |